论文部分内容阅读
将80例初诊为2型糖尿病患者随机分为二组,对照组:早晚用甘舒霖30R,治疗组:三餐前用甘舒霖R及睡前用甘舒霖N,每组各40例。治疗12周后观察其降糖效果。结果:治疗组空腹、餐后2h血糖及低血糖发作例数控制优于对照组(P<0.05),结果有显著性差别。结论:三餐前用甘舒霖R、睡前用甘舒霖N能够有效的控制血糖,减少血糖波动及低血糖发生,安全性及依从性好,值得临床推行。
80 newly diagnosed type 2 diabetic patients were randomly divided into two groups, the control group: sooner or later with Gansu Lin 30R, the treatment group: three meals before Ganshu Lin R and Gansu Lin before going to bed N, each group of 40 cases. After 12 weeks of treatment, the hypoglycemic effect was observed. Results: The treatment group fasting, 2h postprandial blood glucose and hypoglycemic episodes were better than the control group (P <0.05), the results were significantly different. Conclusion: Before meals, Gansu Lin R, before going to bed with Gan Shu Lin N can effectively control blood sugar, reduce blood sugar fluctuations and hypoglycemia, safety and compliance, it is worth clinical implementation.